Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Current Taxes (2016 - 2022)

Altimmune (ALT) has disclosed Current Taxes for 2 consecutive years, with $1.2 million as the latest value for Q3 2022.

  • On a quarterly basis, Current Taxes changed N/A to $1.2 million in Q3 2022 year-over-year; TTM through Sep 2022 was $1.2 million, a N/A change, with the full-year FY2016 number at $3.2 million, changed N/A from a year prior.
  • Current Taxes was $1.2 million for Q3 2022 at Altimmune, down from $3.2 million in the prior quarter.
  • In the past five years, Current Taxes ranged from a high of $1.2 million in Q3 2022 to a low of $1.2 million in Q3 2022.